Drug development is a complex and time-consuming process, and traditional drug research models have obvious limitations, and there is an urgent need to establish a new model system. Organoids are three-dimensional tissue analogues derived from stem cells that have attracted attention for their excellent physiological relevance. Organoid technology has shown great application potential in the fields of disease modeling, drug screening, toxicity testing, and personalized medicine, and can also be combined with organ-on-a-chip technologies to provide a new platform for the construction of complex physiological correlation models and the study of multi-organ interactions. This article reviews the development history of organoid technology and the progress in its research and application in drug development, discusses the challenges and development directions, to provide references for the key process of drug development and help promote the application and development of organoid technology in drug research and development.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |